Product Information

ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) is a generic product labeled by Somerset Therapeutics, LLC, priced at $2.3390 per ML under NDC 70069001925. Its NADAC has been published 71 times since Jul 9, 2025.

FDA first approved this application on Feb 12, 2025. Its Orange Book therapeutic-equivalence code is AN.

ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)

Acetylcysteine
$2.3390per ML

Strength

200 mg/mL

NDC

70069001925

Classification

Generic

Dosage Form

SOLUTION

Route

RESPIRATORY (INHALATION)

Effective Date

10/21/2026

Active Ingredients

ACETYLCYSTEINE

Approval Type

Generic (ANDA)

FDA Application

ANDA219194

FDA Approved

2/12/2025

TE Code

AN

On Market Since

3/4/2025

Pharmacological Classes

Antidote
Antidote for Acetaminophen Overdose
Decreased Respiratory Secretion Viscosity
Increased Glutathione Concentration
Mucolytic
Reduction Activity

Price Statistics

The NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has been published 71 times since Jul 9, 2025, and over the history we have for it it has risen 10.2%. The table below summarizes its recorded NADAC range and movement.

Current price$2.3390 per ML
All-time high$2.6444 (Oct 15, 2025)
All-time low$2.1234 (Jul 9, 2025)
52-week high$2.5310
52-week low$2.1633
Median price$2.3573
Average price$2.3734
Largest weekly change+11.0% (Jul 23, 2025)
Weeks tracked71
Tracking sinceJul 9, 2025

Price History

1W

0.0%

1M

+4.2%

3M

+8.1%

6M

-1.4%

1Y

-9.0%

3Y

N/A

5Y

N/A

All

+10.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 68% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?

The current National Average Drug Acquisition Cost (NADAC) for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), manufactured by Somerset Therapeutics, LLC, is $2.3390 per ML (NDC 70069001925), effective Nov 11, 2026.

How has the price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) changed over time?

Over the history we have for it, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has risen 10.2%. It has been tracked across 71 weekly CMS publications since Jul 9, 2025.

What are the highest and lowest recorded NADAC prices for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?

Since Jul 9, 2025, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has ranged from a low of $2.1234 (Jul 9, 2025) to a high of $2.6444 (Oct 15, 2025), with a median of $2.3573 per ML.

Are there cheaper alternatives to ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), is $0.7432 per ML — about 68% below ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION).

Who manufactures ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?

ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) (NDC 70069001925) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.